A mitochondrial myopathy with a deficiency of respiratory chain NADH-CoQ reductase activity. 1979

J A Morgan-Hughes, and P Darveniza, and D N Landon, and J M Land, and J B Clark

This paper presents data on two sisters with a mitochondrial myopathy characterised by weakness, marked exercise intolerance and a fluctuating lactic acidaemia. Both patients also experienced episodes of increased weakness which could be brought on by unaccustomed activity, going without food or by taking small quantities of alcohol. Metabolic studies during exercise showed a marked and sudden rise in blood lactate and pyruvate levels. Biochemical studies in one case showed that mitochondrial respiratory rates were markedly decreased with all NAD-linked substrates tested but were normal with succinate and with TMPD + ascorbate. The mitochondrial cytochrome components were normal as determined by low temperature spectroscopy and the addition of uncoupler did not enhance state 3 respiratory rates utilising NAD-linked substrates. It was concluded, therefore, that the mitochondrial lesion was located at the level of the NADH-CoQ reductase complex.

UI MeSH Term Description Entries
D008931 Mitochondria, Muscle Mitochondria of skeletal and smooth muscle. It does not include myocardial mitochondria for which MITOCHONDRIA, HEART is available. Sarcosomes,Mitochondrion, Muscle,Muscle Mitochondria,Muscle Mitochondrion,Sarcosome
D009135 Muscular Diseases Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE. Muscle Disorders,Myopathies,Myopathic Conditions,Muscle Disorder,Muscular Disease,Myopathic Condition,Myopathy
D009247 NADH, NADPH Oxidoreductases A group of oxidoreductases that act on NADH or NADPH. In general, enzymes using NADH or NADPH to reduce a substrate are classified according to the reverse reaction, in which NAD+ or NADP+ is formally regarded as an acceptor. This subclass includes only those enzymes in which some other redox carrier is the acceptor. (Enzyme Nomenclature, 1992, p100) EC 1.6. Oxidoreductases, NADH, NADPH,NADPH Oxidoreductases NADH,Oxidoreductases NADH, NADPH
D011808 Quinone Reductases NAD(P)H:(quinone acceptor) oxidoreductases. A family that includes three enzymes which are distinguished by their sensitivity to various inhibitors. EC 1.6.99.2 (NAD(P)H DEHYDROGENASE (QUINONE);) is a flavoprotein which reduces various quinones in the presence of NADH or NADPH and is inhibited by dicoumarol. EC 1.6.99.5 (NADH dehydrogenase (quinone)) requires NADH, is inhibited by AMP and 2,4-dinitrophenol but not by dicoumarol or folic acid derivatives. EC 1.6.99.6 (NADPH dehydrogenase (quinone)) requires NADPH and is inhibited by dicoumarol and folic acid derivatives but not by 2,4-dinitrophenol. Menaquinone Reductases,Reductases, Menaquinone,Reductases, Quinone
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D003579 Cytochrome Reductases Reductases, Cytochrome
D004579 Electron Transport The process by which ELECTRONS are transported from a reduced substrate to molecular OXYGEN. (From Bennington, Saunders Dictionary and Encyclopedia of Laboratory Medicine and Technology, 1984, p270) Respiratory Chain,Chain, Respiratory,Chains, Respiratory,Respiratory Chains,Transport, Electron
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J A Morgan-Hughes, and P Darveniza, and D N Landon, and J M Land, and J B Clark
November 1986, Neuropediatrics,
J A Morgan-Hughes, and P Darveniza, and D N Landon, and J M Land, and J B Clark
April 1988, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
J A Morgan-Hughes, and P Darveniza, and D N Landon, and J M Land, and J B Clark
January 1986, Journal of inherited metabolic disease,
J A Morgan-Hughes, and P Darveniza, and D N Landon, and J M Land, and J B Clark
December 1983, Neurology,
J A Morgan-Hughes, and P Darveniza, and D N Landon, and J M Land, and J B Clark
September 1983, Lancet (London, England),
J A Morgan-Hughes, and P Darveniza, and D N Landon, and J M Land, and J B Clark
February 1988, Neuropediatrics,
J A Morgan-Hughes, and P Darveniza, and D N Landon, and J M Land, and J B Clark
April 1981, Journal of the neurological sciences,
J A Morgan-Hughes, and P Darveniza, and D N Landon, and J M Land, and J B Clark
February 1982, Nature,
J A Morgan-Hughes, and P Darveniza, and D N Landon, and J M Land, and J B Clark
May 2015, Journal of inherited metabolic disease,
J A Morgan-Hughes, and P Darveniza, and D N Landon, and J M Land, and J B Clark
January 1988, Pediatric neurology,
Copied contents to your clipboard!